OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer
Longhui Hao, Wenzheng Wu, Yankun Xu, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2126-2126
Open Access | Times Cited: 25

Showing 25 citing articles:

MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting
Asif Ahmad Bhat, Obaid Afzal, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154991-154991
Closed Access | Times Cited: 57

From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression
Riya Thapa, Obaid Afzal, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154959-154959
Closed Access | Times Cited: 49

Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer
Giovanni Tossetta, Sonia Fantone, Daniela Marzioni, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 7
Open Access | Times Cited: 38

The tale of SOX2: Focusing on lncRNA regulation in cancer progression and therapy
Peng Huang, Feng Wen, YiShan Li, et al.
Life Sciences (2024) Vol. 344, pp. 122576-122576
Closed Access | Times Cited: 9

Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma
Hong Yan, Nan Jiang, M Kellis, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1

Molecular Mechanisms and Therapeutic Implications of Long Non‐coding RNAs in Cutaneous Biology and Disease
Alessandro Zuccotti, Farah Al‐Fatyan, Giulia D. S. Ferretti, et al.
Journal of Cellular Physiology (2025) Vol. 240, Iss. 2
Closed Access | Times Cited: 1

Osteosarcoma in a ceRNET perspective
Nicola Mosca, Nicola Alessio, Alessandra Di Paola, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 5

Beyond the Genome: Deciphering the Role of MALAT1 in Breast Cancer Progression
Md Sadique Hussain, Mohit Agrawal, Nusrat K. Shaikh, et al.
Current Genomics (2024) Vol. 25, Iss. 5, pp. 343-357
Open Access | Times Cited: 4

Mechanism of action of lncRNA-NEAT1 in immune diseases
Ruoxuan Zhang, Zixuan Zhang, Xiaosu Zhao, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access

A Fluorescence Biosensor for Detecting LncRNA MALAT1 Based on Isothermal Amplification by Cyclic Extension
Xue Shixing, Bu Shengjun, He Sun, et al.
Analytica Chimica Acta (2025), pp. 344076-344076
Closed Access

PAK5 promotes the trastuzumab resistance by increasing HER2 nuclear accumulation in HER2-positive breast cancer
Xin Zhao, Yang Li, Hongyan Zhang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access

MALAT1-regulated gene expression profiling in lung cancer cell lines
Jungwook Roh, B Kim, Mijung Im, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10

Plasma-derived exosomal long noncoding RNAs of pancreatic cancer patients as novel blood-based biomarkers of disease
Xiaomeng He, Litian Chen, Di Yang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3

Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key
Xi Zhang, Yunchao Zhang, Qiong Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

LncRNA GATA3-AS1 Promotes Bladder Uroepithelial Cancer Progression by Stabilizing DDX5
Yong Duan, Zonghang Liu, Yongliang Ma, et al.
Journal of Cancer (2024) Vol. 16, Iss. 3, pp. 835-847
Open Access | Times Cited: 1

MIR31HG, a potential lncRNA in human cancers and non-cancers
Luxi Ruan, Jing Lei, Yihang Yuan, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2

The Expression Patterns and Implications of MALAT1, MANCR, PSMA3-AS1 and miR-101 in Esophageal Adenocarcinoma
Athanasios Syllaios, Maria Gazouli, Michail Vailas, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 98-98
Open Access | Times Cited: 2

Effects of Purine Metabolism-Related LINC01671 on Tumor Heterogeneity in Kidney Renal Clear Cell Carcinoma
Wei Yin, Jinhua Wang, Yumei Liang, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 12, pp. 354-354
Open Access | Times Cited: 2

Changes of LncRNAs during the Process of Antioxidants Antagonize Cadmium-Induced Oxidative Damage in Islet β Cells
Rongxian Li, Jiao Dai, Zuoshun He, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 827-837
Closed Access

Long noncoding RNA GPRC5D-AS1 in renal cell carcinoma: a molecular mechanism study
Mingfei Jia, Xi Chen, Shaosan Kang, et al.
Translational Andrology and Urology (2024) Vol. 13, Iss. 2, pp. 230-244
Open Access

Dysregulation of lncRNA MALAT1 Contributes to Lung Cancer in African Americans by modulating the tumor immune microenvironment
Jin Li, Pushpa Dhilipkannah, Van K. Holden, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Long non-coding RNAs in pancreatic cancer
Yuan Chen, Xiaohua Ye, Minli Hu, et al.
Clinica Chimica Acta (2024) Vol. 566, pp. 120040-120040
Closed Access

Page 1

Scroll to top